Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20170818035762N3Phase 3Completed
Phase 3, double-blind trial of betamethasone in verruca (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Post-cryotherapy inflammatory symptoms. Started Apr 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20170818035762N3.